FDA 483 - Pillar5 Pharma Inc. - February 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Pillar5 Pharma Inc., a contract manufacturer in Arnprior, was cited for significant deficiencies in its aseptic processing, quality control, and laboratory operations. The inspection revealed inadequate validation of aseptic processes, poor disinfectant efficacy studies, and failures in thoroughly investigating discrepancies and maintaining stability programs. These issues raise concerns about the sterility assurance and overall quality of drug products manufactured by the firm.
ID · aae128df-7323-4546-9ab7-cb02e0d26682